Stock & Company Details
Rhythm Pharmaceuticals Inc. $RYTM
Price:
46,691,331
69M
$7.6B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-10.92
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
RYTM technical indicators
Latest Rhythm Pharmaceuticals Inc. (RYTM) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
76.35 2.4%
MACD:
5.93 2.9%
SMA 50:
$91.71 0.5%
SMA 200:
$98.07 0.1%
EMA 20:
$100.13 1.1%
Bollinger Bands:
117 / 76.53
Stochastic:
90.66 2.6%
ADX 14:
37.20 5.6%
ATR 14:
4.82 0.4%
CCI 20:
111.36 9.3%
OBV:
41.92M 2.3%
ROC 12:
24.93% 6.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.
Finance Bot
Ask your questions
Start by typing a question below.
